Dexamethasone ophthalmic suspension, 0.1%

DRUG2 trials

Sponsors

Alcon Research

Conditions

Allergic Conjunctivitis

Phase 2

AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation

CompletedNCT01001091

Alcon ResearchAllergic Conjunctivitis

Start: 2009-12-31End: 2010-04-30Updated: 2014-07-17

Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis

CompletedNCT02079649

Alcon ResearchAllergic Conjunctivitis

Start: 2014-04-30End: 2014-07-31Updated: 2015-08-24

Related Papers

Redness response phenotypes of allergic conjunctivitis in an allergen challenge chamber.

2017-01-0112 citations